Clinical Trial Update: Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase III trial evaluating a quadruple regimen of asunaprevir, daclatasvir, pegylated interferon, and ribavirin for he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Asunaprevir (asunaprevir)
• Daclatasvir (daclatasvir)
• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 3 | Status: COMPLETED